136 related articles for article (PubMed ID: 2526762)
1. Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats.
Okabayashi Y; Otsuki M; Ohki A; Tani S; Baba S
Diabetes; 1989 Aug; 38(8):1042-7. PubMed ID: 2526762
[TBL] [Abstract][Full Text] [Related]
2. A comparison between insulin and glucagon release from orthotopically-placed islets of Langerhans and after their transplantation into the liver of diabetic rats.
Blech W; Brömme HJ; Kohnert KD; Blume R; Hildebrandt W; Hahn HJ
Exp Clin Endocrinol; 1989 May; 93(2-3):261-6. PubMed ID: 2528472
[TBL] [Abstract][Full Text] [Related]
3. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.
Otsuki M; Sakamoto C; Yuu H; Maeda M; Morita S; Ohki A; Kobayashi N; Terashi K; Okano K; Baba S
J Clin Invest; 1979 Mar; 63(3):478-84. PubMed ID: 372241
[TBL] [Abstract][Full Text] [Related]
4. Unresponsiveness to glucose in a streptozocin model of diabetes. Inappropriate insulin and glucagon responses to a reduction of glucose concentration.
Leahy JL; Weir GC
Diabetes; 1985 Jul; 34(7):653-9. PubMed ID: 2861128
[TBL] [Abstract][Full Text] [Related]
5. Glucose- and arginine-induced insulin and glucagon responses from the isolated perfused pancreas of the BB-Wistar diabetic rat. Evidence for selective impairment of glucose regulation.
Grill V; Herberg L
Acta Endocrinol (Copenh); 1983 Apr; 102(4):561-6. PubMed ID: 6342326
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands.
Grill V; Rundfeldt M
Diabetes; 1986 Jan; 35(1):44-51. PubMed ID: 2416619
[TBL] [Abstract][Full Text] [Related]
7. Abnormal regulation by glucose of somatostatin secretion in the perfused pancreas of NIDDM rats.
Ostenson CG; Efendic S; Grill V
Pancreas; 1990 May; 5(3):347-53. PubMed ID: 1971441
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas.
Gerich JE; Charles MA; Grodsky GM
J Clin Invest; 1974 Oct; 54(4):833-41. PubMed ID: 4430717
[TBL] [Abstract][Full Text] [Related]
9. Abnormal insulin secretion in a streptozocin model of diabetes. Effects of insulin treatment.
Leahy JL; Bonner-Weir S; Weir GC
Diabetes; 1985 Jul; 34(7):660-6. PubMed ID: 2408948
[TBL] [Abstract][Full Text] [Related]
10. Glucagon secretory responses to insulin-induced hypoglycemia and arginine in streptozotocin-induced diabetic dogs.
Gotoh M; Okamura J; Monden M; Shima K
Endocrinol Jpn; 1983 Aug; 30(4):443-50. PubMed ID: 6368206
[TBL] [Abstract][Full Text] [Related]
11. Gliclazide directly suppresses arginine-induced glucagon secretion.
Takahashi K; Yamatani K; Hara M; Sasaki H
Diabetes Res Clin Pract; 1994 Jul; 24(3):143-51. PubMed ID: 7988345
[TBL] [Abstract][Full Text] [Related]
12. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic hormones in streptozotocin-diabetic rats.
Tomita T; Sasaki S; Doull V; Bunag R; Kimmel JR
Int J Pancreatol; 1986 Oct; 1(3-4):265-78. PubMed ID: 2890693
[TBL] [Abstract][Full Text] [Related]
14. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment.
Inoue K; Hisatomi A; Umeda F; Nawata H
Diabetes; 1992 Jun; 41(6):723-7. PubMed ID: 1534057
[TBL] [Abstract][Full Text] [Related]
15. Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats.
Pagliara AS; Stillings SN; Haymond MW; Hover BA; Matschinsky FM
J Clin Invest; 1975 Feb; 55(2):244-55. PubMed ID: 123928
[TBL] [Abstract][Full Text] [Related]
16. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
Serradas P; Bailbé D; Portha B
Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
[TBL] [Abstract][Full Text] [Related]
17. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
Tachibana I; Akiyama T; Kanagawa K; Shiohara H; Furumi K; Watanabe N; Otsuki M
Am J Physiol; 1996 Apr; 270(4 Pt 1):G730-7. PubMed ID: 8928805
[TBL] [Abstract][Full Text] [Related]
18. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
[TBL] [Abstract][Full Text] [Related]
19. Alpha-adrenergic system in the modulation of pancreatic A and B cell function in normal rats.
Filipponi P; Gregorio F; Ferrandina C; Nicoletti I; Mannarelli C; Pippi R; Santeusanio F
Diabetes Res Clin Pract; 1986; 2(6):325-36. PubMed ID: 2880701
[TBL] [Abstract][Full Text] [Related]
20. Insulin, glucagon, and somatostatin secretion from isolated perfused rat and chicken pancreas-duodenum.
Honey RN; Schwarz JA; Mathe CJ; Weir GC
Am J Physiol; 1980 Feb; 238(2):E150-6. PubMed ID: 6444782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
